Last reviewed · How we verify
NCT05847868: KRIOS
Clinical Evaluation of Moment Tumor Hip Replacement Products
NA trial testing Moment Tumour Hip Prothesis in Primary and Secondary Bone Tumor in the Proximal Femur Region in 42 participants. Completed in 30 June 2025.
30 June 2025
Quick facts
| Lead sponsor | Estas Tıbbi Mamülleri Medikal |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 42 |
| Start date | 16 March 2023 |
| Primary completion | 30 June 2025 |
| Estimated completion | 30 June 2025 |
| Sites | 7 locations across Turkey (Türkiye) |
Drugs / interventions tested
- Moment Tumour Hip Prothesis
Conditions studied
- Primary and Secondary Bone Tumor in the Proximal Femur Region — all drugs for Primary and Secondary Bone Tumor in the Proximal Femur Region →
Sponsor
Estas Tıbbi Mamülleri Medikal
Who can join
Adults 18 to 79, any sex, with Primary and Secondary Bone Tumor in the Proximal Femur Region. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim is to ensure that the patients are functionally adequately and painlessly mobilized with the proximal femoral tumor resection prosthesis used, to increase the survival of patients who underwent wide resection, and to determine the complications of the treatment applied and the clinical performance of the Moment Tumor Hip Replacement Products used.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05847868
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05847868 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Estas Tıbbi Mamülleri Medikal
- Last refreshed: 3 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05847868.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing